Werewolf Therapeutics, Inc.
🏢 View company profile →10Patents
10Active
10Granted
52Portfolio score
Filing activity: Jun 11, 2019 → Feb 9, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10696723B2 | Activatable interleukin 12 polypeptides | Chemistry; Metallurgy | 11 | Active |
| US10696724B2 | Activatable interleukin-2 polypeptides | Chemistry; Metallurgy | 11 | Active |
| US11352403B2 | Activatable interleukin-2 polypeptides and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US12036266B2 | Activatable cytokine polypeptides and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11453710B2 | Activatable interleukin 12 polypeptides and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11739132B2 | Separation moieties and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11981716B2 | Activatable interleukin-2 polypeptides and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US12275769B2 | Activatable interleukin 12 polypeptides and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11535658B2 | Activatable interleukin-2 polypeptides and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US12076371B2 | Activatable cytokine polypeptides and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.